{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:40:38Z","timestamp":1768470038252,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"2014 Korean Association for the Study of the Liver Research Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-3092-7","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:58:57Z","timestamp":1545422337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Yuri","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youn Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwi Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-1007","authenticated-orcid":false,"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"3092_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","volume":"59","author":"J Rehm","year":"2013","unstructured":"Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160\u20138.","journal-title":"J Hepatol"},{"key":"3092_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3350\/cmh.2017.0079","volume":"24","author":"JY Jang","year":"2018","unstructured":"Jang JY, Kim DJ. Epidemiology of alcoholic liver disease in Korea. Clin Mol Hepatol. 2018;24:93\u20139.","journal-title":"Clin Mol Hepatol"},{"key":"3092_CR3","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758\u201369.","journal-title":"N Engl J Med"},{"key":"3092_CR4","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","volume":"110","author":"P Mathurin","year":"1996","unstructured":"Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology. 1996;110:1847\u201353.","journal-title":"Gastroenterology"},{"key":"3092_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/jhep.2002.34734","volume":"36","author":"WR Kim","year":"2002","unstructured":"Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227\u201342.","journal-title":"Hepatology"},{"key":"3092_CR6","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","volume":"103","author":"M Dominguez","year":"2008","unstructured":"Dominguez M, Rincon D, Abraldes JG, et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol. 2008;103:2747\u201356.","journal-title":"Am J Gastroenterol"},{"key":"3092_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, O\u2019Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255\u201360.","journal-title":"Gut"},{"key":"3092_CR8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/MCG.0b013e3181fdef1d","volume":"45","author":"S Liangpunsakul","year":"2011","unstructured":"Liangpunsakul S. Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States. J Clin Gastroenterol. 2011;45:714\u20139.","journal-title":"J Clin Gastroenterol"},{"key":"3092_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","volume":"75","author":"WC Maddrey","year":"1978","unstructured":"Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193\u20139.","journal-title":"Gastroenterology"},{"key":"3092_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/hep.20503","volume":"41","author":"W Dunn","year":"2005","unstructured":"Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353\u20138.","journal-title":"Hepatology"},{"key":"3092_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","volume":"57","author":"European Association for the Study of L","year":"2012","unstructured":"European Association for the Study of L. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:399\u2013420.","journal-title":"J Hepatol"},{"key":"3092_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"RS O\u2019Shea","year":"2010","unstructured":"O\u2019Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Disease and Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2010;51:307\u201328.","journal-title":"Hepatology"},{"key":"3092_CR13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.21607","volume":"45","author":"A Louvet","year":"2007","unstructured":"Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348\u201354.","journal-title":"Hepatology"},{"key":"3092_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","volume":"142","author":"V Garg","year":"2012","unstructured":"Garg V, Garg H, Khan A, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505\u201312 e1.","journal-title":"Gastroenterology"},{"key":"3092_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/hep.22317","volume":"48","author":"L Spahr","year":"2008","unstructured":"Spahr L, Lambert JF, Rubbia-Brandt L, et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology. 2008;48:221\u20139.","journal-title":"Hepatology"},{"key":"3092_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","volume":"48","author":"A Louvet","year":"2008","unstructured":"Louvet A, Diaz E, Dharancy S, et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol. 2008;48:465\u201370.","journal-title":"J Hepatol"},{"key":"3092_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jhep.2006.02.018","volume":"45","author":"S Gaia","year":"2006","unstructured":"Gaia S, Smedile A, Omede P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol. 2006;45:13\u20139.","journal-title":"J Hepatol"},{"key":"3092_CR18","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/ajg.2014.154","volume":"109","author":"V Singh","year":"2014","unstructured":"Singh V, Sharma AK, Narasimhan RL, Bhalla A, Sharma N, Sharma R. Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol. 2014;109:1417\u201323.","journal-title":"Am J Gastroenterol"},{"key":"3092_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1053\/j.gastro.2007.05.018","volume":"133","author":"AC Piscaglia","year":"2007","unstructured":"Piscaglia AC, Shupe TD, Oh SH, Gasbarrini A, Petersen BE. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology. 2007;133:619\u201331.","journal-title":"Gastroenterology"},{"key":"3092_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2013.276300","volume":"310","author":"P Mathurin","year":"2013","unstructured":"Mathurin P, Louvet A, Duhamel A, et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA. 2013;310:1033\u201341.","journal-title":"JAMA"},{"key":"3092_CR21","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","volume":"365","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365:1790\u2013800.","journal-title":"N Engl J Med"},{"key":"3092_CR22","volume-title":"Filgrastim mobilized PBSC days one, two, three and four donor assessment","author":"National Marrow Donor Program","year":"2014","unstructured":"National Marrow Donor Program. Filgrastim mobilized PBSC days one, two, three and four donor assessment. 2014. \n                    https:\/\/www.cibmtr.org\/DataManagement\/TrainingReference\/eLearning\/Documents\/710_sample.pdf\n                    \n                  ."},{"key":"3092_CR23","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1182\/blood-2008-08-175323","volume":"113","author":"MA Pulsipher","year":"2009","unstructured":"Pulsipher MA, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113:3604\u201311.","journal-title":"Blood"},{"key":"3092_CR24","volume-title":"Operational guidelines for the establishment and functioning of data & safety monitoring boards","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Operational guidelines for the establishment and functioning of data & safety monitoring boards. 2004. \n                    http:\/\/www.who.int\/tdr\/publications\/documents\/operational-guidelines.pdf\n                    \n                  ."},{"key":"3092_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3350\/cmh.2013.19.3.216","volume":"19","author":"Korean Association for the Study of the Liver","year":"2013","unstructured":"Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19:216\u201354.","journal-title":"Clin Mol Hepatol"},{"key":"3092_CR26","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:1637\u201348.","journal-title":"Gastroenterology"},{"key":"3092_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/apt.12279","volume":"37","author":"R Parker","year":"2013","unstructured":"Parker R, Armstrong MJ, Corbett C, Rowe IA, Houlihan DD. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther. 2013;37:845\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"3092_CR28","doi-asserted-by":"crossref","unstructured":"Whitfield K, Rambaldi A, Wetterslev J, Gluud C. Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev. 2009;(4):CD007339.","DOI":"10.1002\/14651858.CD007339.pub2"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-3092-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3092-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T19:21:21Z","timestamp":1576956081000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3092-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3092"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-3092-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The trial has been approved by the Institutional Review Board (IRB) of Seoul National University Boramae Medical Center and by the IRBs of the 14 participating centers (Hallym University Medical Center-Chuncheon, Pusan National University Hospital, Pusan National University Yangsan Hospital, Daegu Catholic University Medical Center, Ulsan University Hospital, St. Vincent\u2019s Hospital, Korea University Ansan Hospital, Hanyang University Guri Hospital, Chonbuk National University Hospital, Yonsei University Wonju Severance Christian Hospital, GangNeung Asan Hospital, Uijeongbu St. Mary\u2019s Hospital, Wonkwang University Hospital, and Gyeongsang National University Hospital). Informed consent will be obtained from all participants in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"696"}}